p53 regulates apoptosis in human retinoblastoma

T. M. Nork, G. L. Poulsen, L. L. Millecchia, R. G. Jantz and R. W. Nickells
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, USA.

OBJECTIVES: To determine whether apoptosis is a significant mode of cell death in human retinoblastoma (RB) and if it is regulated by the expression of p53. METHODS: Apoptosis was analyzed using the criterion of internucleosomal DNA degradation as determined by agarose gel electrophoresis of DNA isolated from tumor specimens. Individual cells undergoing apoptosis were identified using terminal transferase-mediated biotin-dUTP nick end labeling (TUNEL) of fragmented DNA. The expression of p53 and WAF1 (a protein involved in p53-mediated cell cycle arrest) in human RB was determined by immunocytochemical analysis. The function of p53 in human RB cell lines was tested by transfecting them with a complementary DNA encoding a temperature-sensitive isoform of murine p53 under the control of a strong viral promoter. RESULTS: DNA from RB tumor specimens showed a strong nucleosomal ladder of DNA fragments typical of apoptosis. The TUNEL staining indicated that poorly and moderately differentiated cells in tumors were undergoing DNA fragmentation. Immunoreactivity for p53 was variable. Cells expressing low levels of p53 seemed viable and expressed WAF1. Cells expressing high levels of p53 were found immediately adjacent to cells undergoing apoptosis. Human RB cells in culture that were expressing a murine temperature-sensitive isoform of p53 died at temperatures that allow this protein to assume a wild-type conformation. CONCLUSIONS: Apoptotic cell death is prevalent in RB. The close association of p53-immunoreactive cells and cells undergoing apoptosis in human tumors, and the ability of exogenous p53 to stimulate cell death in cultured human RB cells, suggests that p53 plays a role in regulating cell death in RB.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuronal Differentiation and Synaptogenesis in Retinoblastoma
Johnson et al.
Cancer Res. 2007;67:2701-2711.
ABSTRACT | FULL TEXT  

MDMX: from bench to bedside
Marine et al.
J. Cell Sci. 2007;120:371-378.
ABSTRACT | FULL TEXT  

Small Molecule Inhibition of HDM2 Leads to p53-Mediated Cell Death in Retinoblastoma Cells.
Elison et al.
Arch Ophthalmol 2006;124:1269-1275.
ABSTRACT | FULL TEXT  

Vitamin D Analogues Increase p53, p21, and Apoptosis in a Xenograft Model of Human Retinoblastoma
Audo et al.
IOVS 2003;44:4192-4199.
ABSTRACT | FULL TEXT  

Transducible Peptide Therapy for Uveal Melanoma and Retinoblastoma
Harbour et al.
Arch Ophthalmol 2002;120:1341-1346.
ABSTRACT | FULL TEXT  

The Wilms' Tumor Suppressor Wt1 Is Associated with the Differentiation of Retinoblastoma Cells
Wagner et al.
Cell Growth Differ. 2002;13:297-305.
ABSTRACT | FULL TEXT  

Adenovirus-Mediated Gene Therapy Using Human p21WAF-1/Cip-1 to Prevent Wound Healing in a Rabbit Model of Glaucoma Filtration Surgery
Perkins et al.
Arch Ophthalmol 2002;120:941-949.
ABSTRACT | FULL TEXT  

Distributions of p53 codon 72 polymorphism in primary open angle glaucoma
Lin et al.
Br. J. Ophthalmol. 2002;86:767-770.
ABSTRACT | FULL TEXT  

Toxicity and Dose-Response Studies of 1{alpha}-Hydroxyvitamin D2 in a Retinoblastoma Xenograft Model
Grostern et al.
Arch Ophthalmol 2002;120:607-612.
ABSTRACT | FULL TEXT  

Observations on 17 Patients With Retinocytoma
Singh et al.
Arch Ophthalmol 2000;118:199-205.
ABSTRACT | FULL TEXT  

Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
Coupland et al.
Br. J. Ophthalmol. 1998;82:961-970.
ABSTRACT | FULL TEXT